Donald Trump's push for lower drug prices to benefit Indian pharma
Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug prices since the country's generic medicines are already affordable, according to industry players.
Jan 26, 2017, 11:15 AM IST